AHKSF
Asahi Kasei Corporation
Set alert
10.42 USD 0.00 0.00%
10.35 Day range 10.35
7.60 52-week range 11.84
- YTD
- +17.02%
- 1 year
- +29.86%
- Open
- 10.35
- Prev close
- 10.42
- Mkt cap
- 13.89B
- Vol
- 100
- Avg vol
- 503
- EPS
- 0.92
- P/E
- 11.32
More statistics
- Low
- 10.35
- High
- 10.35
- Earnings
- Nov 11, 2026
Next earnings
Nov 11, 2026
Expected Nov 11, 2026. Consensus EPS estimate 0.2004.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 11, 2026 | Sep 30, 2026 | 0.2004 | — | — | — |
| Jul 30, 2026 | Jun 30, 2026 | 0.1919 | 0.2443 | +0.05 | +27.31% |
| May 11, 2026 | Mar 31, 2026 | 0.1336 | 0.1773 | +0.04 | +32.71% |
| Feb 3, 2026 | Dec 31, 2025 | 0.2162 | 0.2554 | +0.04 | +18.13% |
| Nov 4, 2025 | Sep 30, 2025 | 0.2293 | 0.2317 | 0.00 | +1.05% |
| Jul 28, 2025 | Jun 30, 2025 | 0.1373 | 0.1002 | -0.04 | -27.02% |
News
- Asahi Kasei Therapeutics Announces FDA Approval of HOVILPRI® (pritelivir) Tablets for Mucocutaneous HSV Lesions Refractory (With or Without Resistance) to Standard Antiviral Treatment in Immunocompromised Adults
- US FDA approves Asahi Kasei's drug for persistent herpes infections
- Asahi Kasei Microdevices Holds IEEE Milestone Commemoration Ceremony in Nobeoka for the Commercialization of Thin-Film Hall Elements
- Asahi Kasei Therapeutics Announces First Patient Dosed in Phase 2a Trial of AIC468 for BK Virus Infection in Kidney Transplant Recipients
- Asahi Kasei to Integrate Global Pharmaceutical Brand Under Asahi Kasei Therapeutics
- Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy Manufacturing
- Asahi Kasei Microdevices' CZ39 and CZ3K Current Sensors Featured in Microchip Technology's Machine Learning-Based Arc Fault Detection Reference Design
- Asahi Kasei Unveils New Wet-Process Separator Coating Line in North Carolina, Advancing the Company's 40-Year North American Battery Separator Strategy
- Asahi Kasei Develops Novel Lithium Pre-doping Technology to Raise Energy Density and Lower Cost of Silicon-rich Lithium-ion Batteries
- Asahi Kasei's Capacity Expansion for Water Electrolysis and Chlor‑Alkali Equipment in Kawasaki Awarded Regional Economic Incentives
Your note
Sign in to keep a note on AHKSF — it syncs with the Stock Master app.